More recently, a 2018 review by Pickart and Margolina in the International Journal of Molecular Sciences synthesized newer gene-expression data, reinforcing earlier remodeling findings with updated molecular pathway detail (PMID 29986520)
Pediatric Postmarketing Pharmacovigilance Review: Bydureon (exenatide) suspension, extended release
Gastrointestinal symptoms during dose changes Nausea, constipation, and other GI symptoms are the most common side effects of GLP-1 therapy, and they tend to re-emerge whenever dosing changes occur
Merck was not the only company pursuing DPP-4 inhibitors
250 mg L-Glutathione per serving With Biotin, Folate, Zinc, Glycine & Omega-3 FDA Approved 25,000+ 5-Star Reviews | Goodies Nutrition